Mohamad Hamieh

7.7k citations

26 papers · 4.6k indexed · 6 hit papers · h-index 14

Co-authors: Michel Sadelain Sjoukje J. C. van der Stegen Justin Eyquem Theodoros Giavridis Jorge Mansilla‐Soto Kristen Cunanan Alessandra Piersigilli Mithat Gönen
Topics: CAR-T cell therapy research (19 papers)Immune Cell Function and Interaction (13 papers)Immunotherapy and Immune Responses (8 papers)
Cited by: Oncology Immunology Genetics
Journals: Nature Nature Medicine Blood
Partner nations: United States France Germany

In The Last Decade

Mohamad Hamieh

26 papers receiving 4.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection

2017 1.3k citations Justin Eyquem, Jorge Mansilla‐Soto et al. Nature profile →
CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade

2018 888 citations Theodoros Giavridis, Sjoukje J. C. van der Stegen et al. Nature Medicine profile →
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape

2019 451 citations Mohamad Hamieh, Anton Dobrin et al. Nature profile →
The pharmacology of second-generation chimeric antigen receptors

2015 430 citations Sjoukje J. C. van der Stegen, Mohamad Hamieh et al. Nature Reviews Drug Discovery profile →
Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

2018 373 citations Judith Feucht, Jie Sun et al. Nature Medicine profile →
Immunogenicity of CAR T cells in cancer therapy

2021 208 citations Dimitrios L. Wagner, Enrico Fritsche et al. Nature Reviews Clinical Oncology profile →

Peers

Countries citing papers authored by Mohamad Hamieh

Since Specialization

Citations

This map shows the geographic impact of Mohamad Hamieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohamad Hamieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohamad Hamieh more than expected).

Fields of papers citing papers by Mohamad Hamieh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohamad Hamieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohamad Hamieh. The network helps show where Mohamad Hamieh may publish in the future.

Co-authorship network of co-authors of Mohamad Hamieh

This figure shows the co-authorship network connecting the top 25 collaborators of Mohamad Hamieh. A scholar is included among the top collaborators of Mohamad Hamieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohamad Hamieh. Mohamad Hamieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthetic dual co-stimulation increases the potency of HIT and TCR-targeted cell therapies 2024 ·Nature Cancer ·Anton Dobrin,(unknown),Yuzhe Shi,Karlo Perica,Hongyao Xie,(unknown),Andrew Chow,Jedd D. Wolchok,Taha Merghoub,Michel Sadelain,Mohamad Hamieh	11
2	Programming CAR T Cell Tumor Recognition: Tuned Antigen Sensing and Logic Gating 2023 ·Cancer Discovery ·Mohamad Hamieh,Jorge Mansilla‐Soto,Isabelle Rivière,Michel Sadelain	84
3	CD19 CAR antigen engagement mechanisms and affinity tuning 2023 ·Science Immunology ·(unknown),Jorge Mansilla‐Soto,(unknown),Mohamad Hamieh,Victor Bustos,Alice J. Paquette,(unknown),Derek M. Shore,William J. Rice,George Khelashvili,Michel Sadelain,Joel R. Meyerson	36
4	Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells 2022 ·Nature Biomedical Engineering ·Sjoukje J. C. van der Stegen,(unknown),Roseanna M. Petrovic,Hongyao Xie,(unknown),Vera Alexeeva,Yuzhe Shi,Jorge Mansilla‐Soto,Mohamad Hamieh,Justin Eyquem,Annalisa Cabriolu,Xiuyan Wang,Ramzey Abujarour,Tom T. Lee,Raedun Clarke,Bahram Valamehr,Maria Themeli,Isabelle Rivière,Michel Sadelain	49
5	Immunogenicity of CAR T cells in cancer therapybreakdown → 2021 ·Nature Reviews Clinical Oncology ·Dimitrios L. Wagner,Enrico Fritsche,Michael A. Pulsipher,Nabil Ahmed,Mohamad Hamieh,Meenakshi Hegde,Marco Ruella,Barbara Savoldo,Nirali N. Shah,Cameron J. Turtle,Alan S. Wayne,Mohamed Abou‐El‐Enein	208
6	Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy 2021 ·Frontiers in Immunology ·Mohamad Hamieh,(unknown),(unknown),(unknown),Émilie Fauquembergue,Pauline Maby,Aurélie Drouet,Anne-Bénédicte Duval-Modeste,Sahil Adriouch,Olivier Boyer,Jean‐Baptiste Latouche	5
7	Brucella prosthetic valve endocarditis with septic and cardiogenic shock 2020 ·IDCases ·(unknown),Mohamad Hamieh	2
8	Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients 2019 ·Cancer Immunology Immunotherapy ·(unknown),Nathalie Josseaume,Quentin Riller,(unknown),(unknown),Claire Deligne,Jean‐Baptiste Latouche,Mohamad Hamieh,(unknown),Olivier Toutirais,Yu Chun Lone,(unknown),Stéphanie Graff‐Dubois,Sandy Amorim,Pascale Loiseau,Antoine Toubert,Pauline Brice,Catherine Thiéblemont,Jean‐Luc Teillaud,Sophie Sibéril	2
9	CAR T cell trogocytosis and cooperative killing regulate tumour antigen escapebreakdown → 2019 ·Nature ·Mohamad Hamieh,Anton Dobrin,Annalisa Cabriolu,Sjoukje J. C. van der Stegen,Theodoros Giavridis,Jorge Mansilla‐Soto,Justin Eyquem,Zeguo Zhao,Benjamin M. Whitlock,Matthew M. Miele,Zhuoning Li,Kristen Cunanan,Morgan Huse,Ronald C. Hendrickson,Xiuyan Wang,Isabelle Rivière,Michel Sadelain	451
10	CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockadebreakdown → 2018 ·Nature Medicine ·Theodoros Giavridis,Sjoukje J. C. van der Stegen,Justin Eyquem,Mohamad Hamieh,Alessandra Piersigilli,Michel Sadelain	888
11	Low-Dose Radiation Conditioning Enables CAR T Cells to Mitigate Antigen Escape 2018 ·Molecular Therapy ·Carl J. DeSelm,M. Lia Palomba,Joachim Yahalom,Mohamad Hamieh,Justin Eyquem,Vinagolu K. Rajasekhar,Michel Sadelain	196
12	Calibration of CAR activation potential directs alternative T cell fates and therapeutic potencybreakdown → 2018 ·Nature Medicine ·Judith Feucht,Jie Sun,Justin Eyquem,Yu-Jui Ho,Zeguo Zhao,Josef Leibold,Anton Dobrin,Annalisa Cabriolu,Mohamad Hamieh,Michel Sadelain	373
13	The ADAMTS13 ^1239–1253 peptide is a dominant HLA-DR1-restricted CD4 ⁺ T-cell epitope 2017 ·Haematologica ·Laurent Gilardin,Sandrine Delignat,Ivan Peyron,(unknown),Yu Chun Lone,Bagirath Gangadharan,Baptiste Michard,Yousra Kherabi,Meenu Sharma,Anastas Pashov,Jean‐Baptiste Latouche,Mohamad Hamieh,Olivier Toutirais,Pascale Loiseau,Lionel Galicier,Agnès Veyradier,Srini V. Kaveri,Bernard Maillère,Paul Coppo,Sébastien Lacroix‐Desmazes	10
14	Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejectionbreakdown → 2017 ·Nature ·Justin Eyquem,Jorge Mansilla‐Soto,Theodoros Giavridis,Sjoukje J. C. van der Stegen,Mohamad Hamieh,Kristen Cunanan,Ashlesha Odak,Mithat Gönen,Michel Sadelain	1307
15	Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML 2017 ·Cancer Cell ·Fabiana Perna,Samuel Berman,Rajesh Soni,Jorge Mansilla‐Soto,Justin Eyquem,Mohamad Hamieh,Ronald C. Hendrickson,Cameron Brennan,Michel Sadelain	226
16	Systematic Combinatorial Chimeric Antigen Receptor Therapies to AML 2017 ·Blood ·Fabiana Perna,Samuel Berman,Rajesh Soni,Jorge Mansilla‐Soto,Justin Eyquem,Mohamad Hamieh,Ronald C. Hendrickson,Cameron Brennan,Michel Sadelain	1
17	Exonic Splicing Mutations Are More Prevalent than Currently Estimated and Can Be Predicted by Using In Silico Tools 2016 ·PLoS Genetics ·Omar Soukarieh,Pascaline Gaildrat,Mohamad Hamieh,Aurélie Drouet,Stéphanie Baert‐Desurmont,Thierry Frébourg,Mario Tosi,Alexandra Martins	117
18	Radiation Sensitizes Tumor Cells to CAR T Cell Immunotherapy 2016 ·International Journal of Radiation OncologyBiologyPhysics ·Carl J. DeSelm,Mohamad Hamieh,Michel Sadelain	4
19	T-cell responses against CD19+ pediatric acute lymphoblastic leukemia mediated by bispecific T-cell engager (BiTE) are regulated contrarily by PD-L1 and CD80/CD86 on leukemic blasts 2016 ·Oncotarget ·Judith Feucht,Simone Kayser,(unknown),Mohamad Hamieh,Michaela Döring,Franziska Blaeschke,Patrick Schlegel,Hans Bösmüller,Leticia Quintanilla-Martı́nez,Martin Ebinger,Peter Lang,Rupert Handgretinger,Tobias Feuchtinger	137
20	The pharmacology of second-generation chimeric antigen receptorsbreakdown → 2015 ·Nature Reviews Drug Discovery ·Sjoukje J. C. van der Stegen,Mohamad Hamieh,Michel Sadelain	430

About Mohamad Hamieh

Mohamad Hamieh is a scholar working on Oncology, Immunology and Parasitology, having authored 26 papers that have together received 4.6k indexed citations. Recurring topics across this work include CAR-T cell therapy research (19 papers), Immune Cell Function and Interaction (13 papers) and Immunotherapy and Immune Responses (8 papers). The work is most often cited by research in Oncology (3.8k citations), Immunology (1.5k citations) and Genetics (1.2k citations). Mohamad Hamieh has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Michel Sadelain, Sjoukje J. C. van der Stegen, Justin Eyquem, Theodoros Giavridis, Jorge Mansilla‐Soto, Kristen Cunanan, Alessandra Piersigilli, Mithat Gönen, Ashlesha Odak and Annalisa Cabriolu. Their work appears in journals such as Nature, Nature Medicine and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact